Dual-gene deletion rough type bovine brucellosis and production method for vaccine thereof
A technology of Brucella bovis and Brucella, applied in the field of veterinary biological products, can solve the problems of roughness and the inability of Brucella to form LPS, etc.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0111]Pancreatic Soy Broth (TSB, BD Company, USA) or other suitable culture medium is used as the culture medium for recombinant bacteria, and an appropriate amount of commonly used antifoaming agent is added according to the medium volume, and 1% to 2% of the medium volume is added after sterilization. Recombinant Brucella rS2 strain seed bacteria liquid, gradually increase the ventilation at 36-37 ° C, and ferment and cultivate for 36 hours according to the conventional method. 1% to 2% of the amount.
[0112] After the cultivation is completed, try to use trypan soy agar to test the purity according to the method stipulated in "Chinese Veterinary Pharmacopoeia", and it is pure.
[0113] At the same time, take samples and count live bacteria with TSA for reference during concentration.
[0114] Add 0.2% to 0.4% of the total amount of sodium carboxymethyl cellulose to the bacterial liquid that has passed the pure inspection to precipitate the bacterial cells, absorb the supe...
Embodiment 2
[0119] Product testing
[0120] The relevant inspection methods involved in the present invention are carried out according to the method of "Chinese Veterinary Pharmacopoeia"
[0121] (1) Physical properties The vaccine should be loose and fast, and can dissolve rapidly within 1 minute after adding the diluent.
[0122] (2) Purely tested vaccines are purely free of other bacteria.
[0123] (3) Safety inspection Dilute the vaccine to contain 1×10 per 1ml 9 CFU live bacteria, subcutaneously inoculate 5 Kunming mice of 18-20 g in the groin, each 0.25 ml / mouse, observe for 6 days, all are healthy and alive (Table 3).
[0124] Table 3 Safety inspection results of rough brucellosis live vaccine (2308-ΔWboA-ΔvjbR strain)
[0125]
[0126] -: Healthy survival, no abnormality at the injection site; +: Death or morbidity.
[0127] (4) Viable bacteria count Use TSA to count the viable bacteria to count the viable bacteria of the vaccine, and the content of viable bacteria in each...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com